End-to-end development:
from drug substance to finished product
Consistent quality is only possible through rigorous control at every stage. We execute full-cycle pharmaceutical development projects—from synthesizing the active substance from high‑quality raw materials to the manufacture of the finished medicinal product.
Our team designs and implements advanced substance synthesis technologies, enabling the production of complex, high‑demand medicines.
Control at every stage, from lab flask to final packaging, delivers three key advantages:
- Quality standardsWe take responsibility for the product from the very first molecule
- Controlled costsIn‑house manufacturing enables cost optimization
- Independence and reliabilityWe ensure stable market supply regardless of external factors
Manufacturing in Russia and the EU
We pursue a consistent strategy to develop efficient and safe manufacturing, adhering to the highest quality standards in medicinal product release and deploying advanced technological solutions. Our facilities are equipped with state‑of‑the‑art systems from leading European manufacturers.
- RussiaJSC “Obninsk Chemical and Pharmaceutical Company”
The production complex is equipped with the latest systems from European manufacturers.
Office: 4 Korolyova St., Obninsk
Manufacturing: Bldg. 107, Kievskoye Highway, Obninsk - Czech RepublicAlven Laboratories S.r.o.
Development and manufacturing of pharmaceutical substances
Holická 1173/49a 779 00 Olomouc Czech Republic - LatviaPHARMIDEA SIA
Development and manufacturing of injectable medicinal products
Rūpnīcu iela 4 Olaine, Olaines novads, LV-2114 Latvija
- In‑house R&D units in Russia and the EU
- In‑house API manufacturing in Russia and the EU
- In‑house finished dosage form (FDF) manufacturing in Russia and the EU
- Bidirectional transfer of analytics and technology (Russia ↔ EU)
- Over 18 years of hands‑on experience in proprietary development, registration, and industrial implementation
- Development of API synthesis technologies
- Scale‑up to industrial level
- Development and validation of analytical control methods
- Preparation of ASMF in CTD format
- Preparation of regulatory documentation (Russia, EAEU)
- Support throughout the registration process
- Commercial API manufacturing at MIRPHARM sites (Russia and the EU)
- Technology transfer to the customer’s site
- Formulation development (solid and liquid forms)
- Scale‑up to industrial level
- Development and validation of analytical control methods
- Preparation of registration dossiers in CTD and EAEU formats
- Conduct of preclinical and clinical studies
- Support throughout the registration process
- Commercial manufacturing of APIs at MIRPHARM sites (Russia and the EU)
- Technology transfer to the customer’s site
Environmental Stewardship
